Davidson Brad, Vogel Victor, Wickerham Lawrence
CommonHealth, 446 Interpace Parkway, Parsippany, NJ 07054, USA.
J Support Oncol. 2007 Mar;5(3):139-43.
Although studies have proven the benefit of 5+ years of adjuvant hormonal therapy (AHT) for breast cancer, data show adherence and persistence with therapy are suboptimal. This observational linguistic study analyzed communication between breast cancer patients and their oncologists to determine how adherence was addressed and to identify areas where communication could be improved. Community-based oncologists were recruited by letter to participate. Researchers visited oncologists (n = 14) to record patient-oncologist interactions and conduct separate post-visit interviews. Comprehensive linguistic analyses of visits between 28 postmenopausal, early-stage breast cancer patients on or initiating hormonal therapy and their oncologists were conducted to determine the nature of discussions of adherence and persistence to therapy. Oncologist-patient discussions about AHT were generally good but did not address potential difficulties of remaining adherent with long-term therapy. Discussions of persistence were usually monologues addressing the current state of "study data" and were not linked to the patient, the importance of persistence, or how the study data related to her situation. Because the patient's cancer was framed as being "in the past," discussions resembled those of chronic management in preventive medicine. This more ad-hoc approach to adherence and persistence is a potential stumbling block for motivating patients to stay on hormonal therapy. Additionally, the oncologists participating in this study recognized that adherence to therapy is a problem but did not feel "their patients" fell into this pattern. In this office-based evaluation, minimal nurse interactions were observed, which increases the importance of oncologist-patient communication. The authors recommend that oncologists leverage the existing good communication with their patients by increasing the amount and quality of discussions around the importance of adherence and persistence to AHT.
尽管研究已证明5年以上的辅助激素治疗(AHT)对乳腺癌有益,但数据显示,患者对治疗的依从性和持续性并不理想。这项观察性语言研究分析了乳腺癌患者与其肿瘤医生之间的沟通情况,以确定如何解决依从性问题,并找出可以改进沟通的领域。通过信函招募社区肿瘤医生参与研究。研究人员拜访肿瘤医生(共14名),记录医患互动情况,并在拜访后单独进行访谈。对28名接受激素治疗或开始激素治疗的绝经后早期乳腺癌患者与其肿瘤医生之间的拜访进行了全面的语言分析,以确定关于治疗依从性和持续性讨论的性质。肿瘤医生与患者关于AHT的讨论总体良好,但未涉及长期治疗保持依从性的潜在困难。关于持续性的讨论通常是独白,涉及“研究数据”的现状,与患者无关,也未提及持续性的重要性,以及研究数据与患者情况的关系。由于将患者的癌症视为“过去的事情”,这些讨论类似于预防医学中慢性病管理的讨论。这种处理依从性和持续性的临时方法可能是激励患者坚持激素治疗的绊脚石。此外,参与本研究的肿瘤医生认识到治疗依从性是个问题,但不认为“他们的患者”存在这种情况。在这项基于办公室的评估中,观察到护士与患者的互动极少,这凸显了医患沟通的重要性。作者建议,肿瘤医生应通过增加围绕AHT依从性和持续性重要性的讨论数量和质量,来利用与患者现有的良好沟通。